Leveraged Loans: The $1.55 Trillion Private Credit Instrument Most Accredited Investors Haven't Touched

The US leveraged loan market crossed $1.55 trillion at the end of 2025, a new record, according to the Morningstar LSTA Leveraged Loan Index December 2025 analysis. That figure represents nine consecutive years of expansion. Yet most accredited investors have never owned a leveraged loan directly and have never bought into a fund built around them. That is not an accident of sophistication. It is an artifact of access. Until recently, meaningful exposure required writing a $5 million to $10 million check into a CLO equity tranche or a private credit partnership. That minimum has collapsed. CLO interval funds from managers like VanEck, Nuveen, and PineBridge now accept as little as $25,000. This guide explains what leveraged loans are, what they pay, what the risks look like right now, and how accredited investors can get exposure in 2026.

What Is a Leveraged Loan?

A leveraged loan is a bank loan made to a company that already carries significant debt or has a below-investment-grade credit rating, typically BB+ or lower from Fitch or Moody's. "Leveraged" simply means the borrower is carrying more debt than a conventional bank would be comfortable holding on its own balance sheet without syndicating the risk.

Two features separate leveraged loans from other corporate debt instruments. First, they are senior secured. If the borrowing company defaults, leveraged loan holders have a first claim on assets before bondholders, preferred equity holders, and common stockholders get anything. That structural priority does not guarantee full recovery, but it produces meaningfully higher recovery rates than unsecured bonds. Historical recovery rates run 60-70 cents on the dollar versus 40-50 cents for high-yield bonds.

Second, leveraged loans carry floating interest rates. The coupon adjusts with SOFR (the Secured Overnight Financing Rate), the benchmark that replaced LIBOR. When rates rise, loan income rises with them. When rates fall, income falls. This floating-rate structure makes leveraged loans a natural hedge against inflation and rising rates, a defining characteristic that drove the $110 billion May 2026 refinancing wave as borrowers raced to lock in terms before spreads moved again.

Leveraged loans are created in two primary contexts: leveraged buyouts (LBOs), where private equity firms borrow against the target company's assets to finance the acquisition, and corporate acquisitions where existing companies fund deals with syndicated debt. The loans are then packaged into Collateralized Loan Obligations (CLOs), which are structured vehicles that buy diversified pools of these loans and issue tranched securities backed by the cash flows. For a full breakdown of CLO mechanics, see our CLO accredited investor guide.

What Leveraged Loans Yield Right Now

As of March 31, 2026, the Morningstar LSTA US Leveraged Loan Index showed a yield-to-maturity of 8.31%, built on a nominal spread of SOFR + 313 basis points. The all-in coupon, accounting for floors and fees, runs approximately 6.81%, per Morgan Stanley's Floating-Rate Loan Market Monitor for Q1 2026.

That yield sits above investment-grade corporate bonds and comparable to or better than many high-yield bond funds, with one structural difference: the floating-rate base. High-yield bonds are predominantly fixed-rate instruments. When SOFR falls, high-yield bond prices rise but the coupon stays fixed. Leveraged loan coupons reset periodically, typically every 30-90 days, so they carry less duration risk but more income uncertainty.

The comparison is worth making explicit. A BB-rated five-year high-yield bond might price at a 7.5% fixed coupon. A BB-rated leveraged loan at SOFR + 300 bps would currently yield roughly 8.1% floating. The loan pays more today and protects the investor if rates stay elevated. The bond pays a fixed stream and benefits if rates drop. Neither is inherently better. The question is what the investor believes about the rate environment over the holding period.

Spreads have compressed significantly since late 2023. Institutional demand from CLO managers, which collectively buy 60-70% of all new leveraged loan issuance, has kept technical conditions tight. That supply-demand dynamic has pushed yields down from the 10-11% range seen during the 2022-2023 rate shock. Investors entering the market today are getting lower compensation for credit risk than those who entered 18 months ago. That matters when assessing value. For context on where private credit pricing fits within the broader yield spectrum, see our private credit 2026 yield and risk analysis.

Covenant-Lite: What 83% Means for Your Risk

In 2010, roughly 15% of institutional leveraged loans were "covenant-lite." By 2025, that number reached 83%, according to the LCD Comps Database and Preqin Direct Lending Survey data. In private credit, the figure approaches 95%.

A covenant is a contractual test the borrower must pass periodically, typically a leverage ratio (total debt divided by EBITDA), an interest coverage ratio, or a minimum liquidity threshold. If the borrower fails a maintenance covenant, the lender gains negotiating position and can demand additional collateral, accelerate repayment, or renegotiate terms before the situation deteriorates further.

Covenant-lite loans strip those maintenance tests out. The borrower is not required to demonstrate ongoing financial health on a quarterly basis. Lenders only have recourse when the borrower actually defaults on a payment or triggers an incurrence covenant, which fires only when the borrower wants to take a new action, like issuing more debt.

This matters in a downturn because covenant-lite structures remove the early-warning system. Lenders cannot force a renegotiation when a borrower's leverage ratio deteriorates from 5x to 7x. They must wait until payments stop. By then, the borrower's assets may have declined in value and recovery prospects have worsened. The current payment default rate of 1.35-1.44% (May-June 2026, per PitchBook LCD and Morningstar LSTA Index data) remains manageable. But the distress ratio — the share of loans trading below 80 cents on the dollar — peaked at 7.23% in March 2026, the highest reading since December 2022. That gap between payment defaults and distress ratios is the covenant-lite problem made visible. Borrowers are not missing payments yet. But a significant slice of the market is trading as if they might.

The 2026 Maturity Wall

Approximately $427 billion in leveraged loans mature between 2026 and 2028. A meaningful portion of those borrowers carry leverage above 6x EBITDA, a ratio that was financeable at 2020-2021 interest rates but creates serious strain at today's levels.

Borrowers with strong fundamentals are refinancing now. May 2026 saw $110 billion in refinancing activity across the leveraged loan market, a monthly record. But the $25.4 billion spike in amend-and-extend transactions in the same month tells the other side of that story. Amend-and-extend is the corporate equivalent of rolling credit card debt: the borrower negotiates with existing lenders to push the maturity date out in exchange for a higher spread or additional fees. It is not a distress signal on its own. Done in volume, it signals that a cohort of borrowers cannot access the new-issue market on terms they can afford.

Borrowers above 6x leverage attempting to refinance in 2026-2027 face rates in the 10-12% range. For companies generating thin EBITDA margins, that refinancing cost can consume all free cash flow. Some will succeed. Others will pursue debt-for-equity swaps or distressed exchanges, which are technical defaults that Fitch and Moody's count differently than payment defaults but represent real credit events for investors. The maturity wall is not a crisis for the overall market. It is a sorting mechanism. High-quality borrowers refinance at manageable rates. Marginal borrowers face an increasingly difficult path. Investors need to know which category their CLO manager or BDC has concentrated exposure in. For a comparison of direct lending versus broadly syndicated loans and how each handles maturity risk, see our direct lending versus BSL comparison.

How Accredited Investors Access Leveraged Loans

Three main vehicles give accredited investors practical access to leveraged loan returns.

CLO Interval Funds. VanEck, Nuveen, and PineBridge have each launched CLO interval funds targeting accredited investors with minimums ranging from $25,000 to $100,000. These funds invest primarily in CLO debt tranches (rated BB through AAA) and, in some structures, CLO equity. They offer quarterly liquidity, typically allowing redemptions of 5-25% of NAV per quarter. Targeted IRRs sit at 13% or above on equity-oriented strategies, with lower but more stable returns on the debt-tranche-focused products. This access point did not exist for most accredited investors five years ago. It is now the most practical entry point for diversified leveraged loan exposure without direct loan selection. For a deeper look at interval fund mechanics and liquidity terms, see our interval funds accredited investor guide.

Business Development Companies (BDCs). BDCs are publicly traded or non-traded investment companies that lend directly to middle-market companies, most of which carry significant debt loads. Because they are registered investment companies subject to SEC oversight, BDCs can be purchased through a standard brokerage account with no minimum beyond the share price. Publicly traded BDCs like Ares Capital, Blue Owl Capital, and FS KKR provide daily liquidity at NAV-proximate prices. Non-traded BDCs offer less liquidity but often lower correlation to public market volatility. Many BDCs currently yield 10-13% through dividends, though underlying portfolio credit quality varies significantly. For a full breakdown, see our BDC accredited investor guide.

Direct Lending Funds. Managers like Crescent Capital, Barings, and StepStone run closed-end private credit funds that originate leveraged loans directly to companies rather than purchasing them in the secondary market. These funds typically require $250,000 to $1 million minimums, carry five-to-seven-year lockups, and target gross IRRs of 12-16%. The illiquidity premium is real, but so is the commitment. These are appropriate for accredited investors with long time horizons and portfolios large enough to absorb a multi-year lockup without straining overall liquidity.

Leveraged Loans vs. Direct Lending vs. High-Yield Bonds

Feature	Leveraged Loans (BSL)	Direct Lending	High-Yield Bonds
Seniority	Senior secured, first lien	Senior secured, first lien	Usually unsecured or second lien
Rate Structure	Floating (SOFR-based)	Floating (SOFR-based)	Fixed rate
Current Yield (2026)	8.31% YTM	11-14% gross IRR	7-9% (BB-B rated)
Covenant Protection	83% covenant-lite	Maintenance covenants typical	Incurrence covenants only
Liquidity	Secondary market, T+7 typical	Illiquid, 5-7 year lockup	Exchange-traded or OTC, high liquidity
Duration Risk	Low (floating rate)	Low (floating rate)	High (fixed rate, 5-10 yr maturities)
Recovery Rate (historical)	60-70 cents on dollar	65-80 cents on dollar	40-50 cents on dollar
Min. Accredited Access	$25K (CLO interval fund)	$250K-$1M (direct fund)	$1K (ETF or mutual fund)

Jeff's Take

I have spent the last several months looking closely at the leveraged loan market, and my honest read is this: the asset class is structurally attractive and tactically complicated right now.

The structural case is real. Senior secured, floating-rate debt in an environment where rates are staying higher for longer than most people expected two years ago is a sensible place to be. The 8.31% yield-to-maturity is not spectacular, but it is senior secured. If something goes wrong, you have a first claim on assets. You are not last in line. For an accredited investor building a private credit sleeve, a CLO interval fund through VanEck or Nuveen is a reasonable way to get there with $25,000 to $50,000 and quarterly liquidity.

What concerns me is the covenant-lite concentration. 83% of this market has stripped out maintenance covenants. That was a fine bet in 2021 when companies were printing record EBITDA and rates were near zero. It is a different bet today. The 7.23% distress ratio we saw in March 2026 is not a crisis number, but it is a signal that a real slice of the market is trading on hope rather than fundamentals. That figure is the highest since December 2022.

The maturity wall gives me more pause than any single data point. $427 billion maturing through 2028. A significant portion of those borrowers are above 6x leverage. They need to refinance at 10-12%. Some will succeed. Some will not. The $25.4 billion amend-and-extend spike in May 2026 tells me the "won't" category is larger than the new-issue volume suggests. CLO managers who have been disciplined about credit selection will navigate this fine. CLO managers who chased yield in 2021 and 2022 by buying overleveraged names are going to have uncomfortable conversations with their investors over the next 18 months.

My approach: I want leveraged loan exposure through managers who have demonstrated credit discipline across a full cycle, not just the 2020-2023 recovery. That means asking hard questions about vintage concentration, the percentage of the portfolio above 6x leverage, and how the manager handled covenant-lite positions in previous stress periods. If those answers are vague, I move on. The asset class is worth owning. The manager selection is what determines whether it performs.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.